Advertisement

Neuro-Urological Management of the Neuropathic Bladder in Children with Myelodysplasia

  • Tufan Tarcan
  • Stuart Bauer

Abstract

Myelodysplasia, which refers to developmental anomalies of the spinal cord caused by closure defects of the neural tube, is the leading cause of neurogenic bladder dysfunction (NBD) in children. Myelo — menin gocele (MMC), the most common form of open spinal dysraphism, constitutes at least 90% of neural tube defects compatible with life leading to NBD. Classification and terminology of neural tube defects is beyond the scope of this chapter and is discussed elsewhere in this book.

Keywords

Spina Bifida Detrusor Overactivity Urethral Sphincter Detrusor Muscle Clean Intermittent Catheterization 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sharpe N (1915) Spina bifida. An experimental and clinical study. Ann Surg 61:151–165PubMedCrossRefGoogle Scholar
  2. 2.
    Mayo-Robson AW (1885) A series of cases of spina bifida treated by plastic operation. Trans Clin Soc Lond 18:210–220Google Scholar
  3. 3.
    Beckman EH, Adson AW (1917) Spina bifida: Its operative treatment. St Paul Med J 19:357–363Google Scholar
  4. 4.
    Siris IE (1936) Spina bifida: Treatment and analysis of 84 cases. Ann Surg 103:97–123PubMedCrossRefGoogle Scholar
  5. 5.
    Ingraham FD, Swan H (1943) Spina bifida and cranium bifidum. I: A survey of five hundred forty-six cases. N Eng J Med 228:559–563Google Scholar
  6. 6.
    Lorber J (1973) Early results of selective treatment of spina bifida cystica. Br Med J 4:201–204PubMedCrossRefGoogle Scholar
  7. 7.
    McGuire EJ, Bloom DA, Ritchey ML (1993) Myelo — dysplasia. Problems in urology. Vol 7(1) part 2:1–14Google Scholar
  8. 8.
    Tarcan T, Önol FF, İlker Y et al (2006) Early primary repair improves the neurourological prognosis significantly in infants with myelomeningocele. J Urol 176:1161–1165PubMedCrossRefGoogle Scholar
  9. 9.
    Kaefer M, Pabby A, Kelly M et al (1999) Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele. J Urol 162:1068–1071PubMedCrossRefGoogle Scholar
  10. 10.
    Tarcan T, Bauer SB, Olmedo E et al (2001) Long-term follow up of newborns with myelodysplasia and normal urodynamic findings: Is follow up necessary? J Urol 165:564–567PubMedCrossRefGoogle Scholar
  11. 11.
    Bauer SB, Labib KB, Dieppa RA et al (1977) Urodynamic evaluation in a boy with myelodysplasia and incontinence. Urology 10:354–362PubMedCrossRefGoogle Scholar
  12. 12.
    Bauer SB (1992) Neurogenic vesical dysfunction in children. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds) Campbell’s urology. WB Saunders, Philadelphia, pp 1634–1668Google Scholar
  13. 13.
    Bauer SB (1988) Early evaluation and management of children with spina bifida. In: King LR (ed) Urologic surgery in neonates and young infants. WB Saunders, Philadelphia, pp 252–264Google Scholar
  14. 14.
    Yamada S, Iacono RP, Andrade T et al (1995) Pathophysiology of tethered cord syndrome. Neurosurg Clin N Am 6:311–323PubMedGoogle Scholar
  15. 15.
    Koh C, DeFilippo R, Bauer SB et al (2006) Lower urinary tract function after fetal closure of myelomennigocele. J Urol 176:2232–2236PubMedCrossRefGoogle Scholar
  16. 16.
    Tarcan T, Önol FF, İlker Y et al (2006) Does surgical release of the secondary spinal cord tethering improve the prognosis of neurogenic bladder in children with myelomeningocele? J Urol 176:1601–1606PubMedCrossRefGoogle Scholar
  17. 17.
    Yücel S, Ertuěrul A, İlker Y et al (2000) The incidence of undescended testis in children with myelodysplasia and its relation with spinal level of the lesion. Turk J Urol 26:328–331Google Scholar
  18. 18.
    Kroovand RL, Bell W, Hart LJ et al (1990) The effect of back closure on detrusor function in neonates with myelodysplasia. J Urol 144:423–425PubMedGoogle Scholar
  19. 19.
    Hopps CV, Kropp KA (2003) Preservation of renal function in children with myelomeningocele managed with basic newborn evaluation and close followup. J Urol 169:305–308PubMedCrossRefGoogle Scholar
  20. 20.
    Teichman JM, Scherz HC, Kim KD et al (1994) An alternative approach to myelodysplasia management: aggressive observation and prompt intervention. J Urol 152(2 Pt 2):807–811PubMedGoogle Scholar
  21. 21.
    Stark G (1968) The pathophysiology of the bladder in myelomeningocele and its correlation with the neurolo — gical picture. Dev Med Child Neurol (Suppl) 16:76–86Google Scholar
  22. 22.
    Bauer SB (1985) The management of spina bifida from birth onwards. In: Whitaker RH, Woodard JR (eds) Pediatric urology. Butterworth & Co, London, pp 87–112Google Scholar
  23. 23.
    Chiaramonte RM, Horowitz EM, Kaplan GA et al (1986) Implications of hydronephrosis in newborns with myelodysplasia. J Urol 136:427–429PubMedGoogle Scholar
  24. 24.
    Bauer SB (1984) Myelodysplasia: Newborn evaluation and management. In: McLaurin RL (ed) Spina bifida: A multidisciplinary approach. Praeger, New York, pp 262–267Google Scholar
  25. 25.
    Spindel MR, Bauer SB, Dyro FM et al (1987) The changing neuro-urologic lesion in myelodysplasia. JAMA 258:1630–1633PubMedCrossRefGoogle Scholar
  26. 26.
    McGuire EJ, Woodside JR, Borden TA et al (1981) Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 126:205–209PubMedGoogle Scholar
  27. 27.
    Shapiro SR, Lebowitz R, Colodny AH (1975) Fate of 90 children with ileal conduit urinary diversion a decade later: analysis of complications, pyelography, renal function and bacteriology. J Urol 114:289–295PubMedGoogle Scholar
  28. 28.
    Lapides J, Diokno AC, Silber SJ et al (1972) Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107:458–461PubMedGoogle Scholar
  29. 29.
    Barbalias GA, Klauber GT, Blaivas JG (1983) Critical evaluation of the Credé maneuver: A urodynamic study of 207 patients. J Urol 130:720–723PubMedGoogle Scholar
  30. 30.
    Tarcan T, Önol FF, Tanıdır Y et al (2007) Are myelo — displastic children receiving sufficient health care in Turkey? An analysis of the problems in primary management and their impact on neurourological outcome. J Ped Urol 3:19–23CrossRefGoogle Scholar
  31. 31.
    Bauer SB (1984) Vesico-ureteral reflux in children with neurogenic bladder dysfunction. In: Johnston JH (ed) International perspectives in urology, Vol 10, Williams & Wilkins, Baltimore pp 159–177Google Scholar
  32. 32.
    Joseph DB, Bauer SB, Colodny AH et al (1989) Clean intermittent catheterization in infants with neurogenic bladder. Pediatrics 84:78–82PubMedGoogle Scholar
  33. 33.
    Mandell J, Bauer SB, Colodny AH, Retik AB (1981) Cuteneous vesicostomy in infancy. J Urol, 126:92–93PubMedGoogle Scholar
  34. 34.
    Kaplan WE, Firlit CF (1983) Management of reflux in myelodisplastic children. J Urol 129:1195–1197PubMedGoogle Scholar
  35. 35.
    Edelstein RA, Bauer SB, Kelly MD et al (1995) The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J Urol 154:1500–1504PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • Tufan Tarcan
    • 1
  • Stuart Bauer
    • 2
  1. 1.Department of UrologyMarmara University Medical CenterIstanbulTurkey
  2. 2.Department of Urology Boston Children’s HospitalHarvard Medical SchoolBostonUSA

Personalised recommendations